• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ANGIOMED GMBH & CO. MEDIZINTECHNIK KG LIFESTENT VASCULAR STENT Back to Search Results
Catalog Number UNK LIFESTENT VASCSTNT SYS
Device Problem Fracture (1260)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/22/2023
Event Type  malfunction  
Event Description
It was reported that approximately one month post stent placement procedure in the femoral artery, the stent allegedly fractured.There was no reported patient injury.
 
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The device has not returned to the manufacturer for evaluation.However, images were provided for review.The investigation of the reported event is currently underway.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that approximately one month post stent placement procedure in the femoral artery, the stent allegedly fractured.There was no reported patient injury.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was not required as the lot number for the device was not provided.Investigation summary: the physical device was not returned for evaluation.Provided images demonstrate overlappingly placed stents in the sfa and complete transversal fracture directly distal to the overlapping zone; further distal the stent has a multiple strut fracture.The investigation leads to confirmed result for strut fracture.Therefore, based on the investigation of the provided information, the investigation is closed as confirmed for the reported strut fracture issue.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product, the potential issue was found addressed.The instructions for use closely describes holding and handling of the system for regular deployment, in particular the instructions for use states: 'confirm that the introducer sheath is secure and will not move during deployment firmly hold the black system stability sheath throughout deployment.Do not hold the silver stent delivery sheath.Do not constrict the stent delivery sheath during stent deployment'.In regard to pta the instructions for use states: 'predilation of the lesion should be performed using standard techniques', and 'post stent expansion with a pta catheter is recommended'.Regarding access and accessories, the instructions for use states: 'gain femoral access utilizing a 6f (2.0 mm) or larger introducer sheath.Insert a 0.035 inch (0.89 mm) diameter guidewire'.Stent fracture was found mentioned as a potential adverse event that may occur; the instructions for use further states: 'cases of fracture have been reported in lesions that were moderate to severely calcified, proximal, or distal to an area of stent overlap and in cases where stents experienced 10% elongation at deployment.Therefore, care should be taken when deploying the stent as manipulation of the delivery system may, in rare instances, lead to stent elongation and subsequent stent fracture'.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFESTENT VASCULAR STENT
Type of Device
VASCULAR STENT
Manufacturer (Section D)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM  76227
Manufacturer (Section G)
ANGIOMED GMBH & CO. MEDIZINTECHNIK KG
wachhausstr. 6
karlsruhe 76227
GM   76227
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17142568
MDR Text Key317319783
Report Number9681442-2023-00233
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P070014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/21/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNK LIFESTENT VASCSTNT SYS
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/21/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-